Cymechs Inc (160980) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Cymechs Inc KRW 33,561, price KRW 26,850, upside +25.0%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Cymechs Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
CYMECHS Inc., a tool automation company, engages in the provision of core system components for semiconductor manufacturing in South Korea. The company offers transfer-equipment, such as transfer modules, EFEM, aligners, LPM, ATM robot for EFEM, and vacuum robot with transfer chambers. It is also involved in the provision of intelligent robot solutions.
Show more
CYMECHS Inc., a tool automation company, engages in the provision of core system components for semiconductor manufacturing in South Korea. The company offers transfer-equipment, such as transfer modules, EFEM, aligners, LPM, ATM robot for EFEM, and vacuum robot with transfer chambers. It is also involved in the provision of intelligent robot solutions. The company was incorporated in 2005 and is headquartered in Hwaseong-si, South Korea.
Stock analysis
Cymechs Inc (160980) currently trades at 26,850 KRW, while our model-based Fair Value estimate is 33,561 KRW, implying the stock looks roughly 20.0% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 52,115 KRW per share, and 16 of the 26 models we run sit above the 26,850 KRW price.
Bear case: the Dividend Discount group reads lowest at 3,822 KRW, and 10 of the 26 models stay below the price. Evidence for this calculation is medium.
Scenario range: 25,171 KRW (bear) to 41,951 KRW (bull), the price of 26,850 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Technology sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Cymechs Inc reported revenue of 164B KRW in FY2025 versus 242B KRW in FY2021, a compound −9.2%/yr. Reported net income was 14.9B KRW in FY2025, compounding −11.5%/yr from FY2021.
Key figures
Market cap 425B KRW (≈ $312M) · P/S ratio 2.67 · Dividend yield 1.5% · Net margin 9.1% · Return on equity 7.2% · Return on assets (EBIT) 9.1% · Operating margin 11.7% · Revenue (TTM) 159B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 92% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −22% fair-value upside, at 25%, 160980 screens cheaper than that median.
Fair Value models
Bear 25,171 KRWFair Value 33,561 KRWBull 41,951 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−0.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.0%
Start year 2020 (pandemic). Over 10 years: +11.5% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−7.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−9.4%
Dividend (yield on the price)1.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−9% vs 6%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 14%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−7.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −9.1% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductor Equipment & Materials · 219 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Cymechs Inc Fair Value". https://www.fairvalue-calculator.com/stock/160980
Frequently asked questions
Is Cymechs Inc (160980) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 33,561 KRW versus a price of 26,850 KRW, about +25% upside (undervalued).
What is the fair value of 160980?
Our model-based fair value for Cymechs Inc is 33,561 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 26,850 KRW.
What is the quality score of 160980?
Cymechs Inc has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cymechs Inc (160980)?
Our model-based price target is the fair value of 33,561 KRW (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 25,171 KRW, optimistic scenario 41,951 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cymechs Inc stock forecast for 2026?
Our models put fair value at 33,561 KRW, about +25% upside versus a price of 26,850 KRW (undervalued). Cautious scenario 25,171 KRW, optimistic scenario 41,951 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cymechs Inc (160980)?
Cymechs Inc reported trailing-twelve-month revenue of about 159B KRW (latest available figure, as of Sep 24, 2026).
Does Cymechs Inc pay a dividend?
Cymechs Inc currently shows a dividend yield of about 1.49% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Cymechs Inc (160980)?
For today's price to be fair in a discounted-cash-flow model, Cymechs Inc would have to grow free cash flow by -7.2 % per year for five years (discount rate 12.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -1.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 160980 use?
Our models discount Cymechs Inc at 12.7 %: a base by market capitalisation (small), damped by beta 1.35, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cymechs Inc that is -7.2 % per year a year over ten years, using the same discount rate (12.7 %) and the same formula as our fair value.
How much growth has Cymechs Inc (160980) delivered so far?
Over the past 5 years revenue at Cymechs Inc grew -1.0 % a year. The price currently implies -7.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cymechs Inc (160980) growing?
The median revenue growth in the sector is +8.2 % a year. That is the yardstick for the growth priced into Cymechs Inc (-7.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cymechs Inc (160980)?
The free-cash-flow yield on the price is 14.60 %: that much free cash flow Cymechs Inc produces per unit of market value. When it exceeds the discount rate of our models (12.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cymechs Inc (160980)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cymechs Inc it is 33,561 KRW per share (as of Sep 24, 2026), against a price of 26,850 KRW. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Cymechs Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 160980 trades below its calculated fair value: price 26,850 KRW, fair value 33,561 KRW, a gap of about +25% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 160980?
No. The price is what the market pays today (26,850 KRW); the fair value is what the company's own numbers justify (33,561 KRW). For Cymechs Inc the two are 6,711 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cymechs Inc worth?
The market values Cymechs Inc at about 425B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 26,850 KRW; our models calculate a fair value of 33,561 KRW per share.
What do the bullish and bearish scenarios say about 160980?
Our models span a range for Cymechs Inc: cautious scenario 25,171 KRW, base 33,561 KRW, optimistic 41,951 KRW per share (as of Sep 24, 2026, price 26,850 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cymechs Inc (160980)?
Balance-sheet figures for Cymechs Inc (as of Sep 24, 2026): return on equity 7.2%. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is 160980 from its 52-week high?
Cymechs Inc trades at 26,850 KRW, about 42% below its 52-week high of 46,500 KRW and 92% above the low of 14,000 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 33,561 KRW is for.
Which stocks are comparable to Cymechs Inc?
From the same area (Technology) we also value ASML Holding, Lam Research Corporation, Applied Materials, Inc, KLA Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cymechs Inc stock attractive at the current price?
The data as of Sep 24, 2026: price 26,850 KRW, calculated fair value 33,561 KRW (+25%), Quality Score 67/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 160980 calculated?
We run Cymechs Inc through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 33,561 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Cymechs Inc currently trades 25 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cymechs Inc (160980)?
The closing price on Sep 23, 2026 was 26,850 KRW. Our model-based fair value is 33,561 KRW, about +25% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cymechs Inc right now?
Solid quality (67/100) at a price below fair value, the discount is the argument here, not the business quality. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Cymechs Inc
How large is the market capitalisation of Cymechs Inc (160980)?
The market capitalisation of Cymechs Inc is 425B KRW (≈ $312M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cymechs Inc (160980)?
The price-to-sales ratio of Cymechs Inc is 2.67 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Cymechs Inc (160980)?
The dividend yield of Cymechs Inc is 1.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cymechs Inc (160980)?
The net margin of Cymechs Inc is 9.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cymechs Inc (160980)?
The return on equity (ROE) of Cymechs Inc is 7.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cymechs Inc (160980)?
On an EBIT basis the return on assets of Cymechs Inc is 9.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cymechs Inc (160980)?
The operating margin of Cymechs Inc is 11.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cymechs Inc (160980)?
Revenue at Cymechs Inc is growing −11.6% versus a year earlier (3y avg −5.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cymechs Inc (160980)?
Earnings per share at Cymechs Inc are growing −33.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Cymechs Inc (160980) carry?
The net debt of Cymechs Inc is 27.4B KRW (fiscal year 2022, ≈ 0.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Cymechs Inc in the live analysis
One click puts Cymechs Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
